AIMP1/p43, is a noncatalytic component of the mammalian multi-tRNA synthetase complex that catalyzes the ligation of amino acids to their cognate tRNAs. AIMP1 is largely expressed in the central nervous system, where it is part of the regulatory machine of the neurofilament assembly, playing a crucial role in neuronal development and function. To date, nonsense mutations in AIMP1 have been associated with a primary neurodegenerative disorder consisting of cerebral atrophy, hypomyelination, microcephaly and epilepsy, whereas missense mutations have recently been linked to intellectual disability without neurodegeneration. Here, we report the first French-Canadian patient with a novel frameshift AIMP1 homozygous mutation (c.191_192delAA, p.Gln64Argfs*25), resulting in a severe neurodegenerative phenotype. We review and discuss the phenotypic spectrum associated with AIMP1 pathogenic variants.
QuevillonSRobinsonJCBerthonneauE. Macromolecular assemblage of aminoacyl-tRNA synthetases: identification of protein-protein interactions and characterization of a core protein. J Mol Biol. 1999;285:183–195.
2.
ParkSGChoiECKimS. Aminoacyl-tRNA synthetase interacting multifunctional proteins (AIMPs): a triad for cellular homeostasis. IUBMB Life. 2010;62:296–302.
3.
LiangDHalpertMMKonduriVDeckerWK. Stepping out of the cytosol: AIMp1/p43 potentiates the link between innate and adaptive immunity. Int Rev Immunol. 2015;34:367–381.
4.
LariviereRCJulienJP. Functions of intermediate filaments in neuronal development and disease. J Neurobiol. 2004;58:131–148.
5.
ZhuXLiuYYinY. MSC p43 required for axonal development in motor neurons. Proc Natl Acad Sci U S A. 2009;106:15944–15949.
6.
FeinsteinMMarkusBNoymanI. Pelizaeus-Merzbacher like disease caused by AIMP1/p43 homozygous mutation. Am J Hum Genet. 2010;87:820–828.
7.
ArmstrongLBiancheriRShyrC. AIMP1 deficiency presents as a cortical neurodegenerative disease with infantile onset. Neurogenetics. 2014;15:157–159.
8.
Gonzaga-JaureguiCHarelTGambinT. Exome sequence analysis suggests that genetic burden contributes to phenotypic variability and complex neuropathy. Cell Rep. 2015;12:1169–1183.
9.
IqbalZPüttmannLMusanteL. Missense variants in AIMP1 gene are implicated in autosomal recessive intellectual disability without neurodegeneration. Eur J Hum Genet. 2016;24:392–399.
10.
BeaulieuCLMajewskiJSchwartzentruberJ. FORGE Canada Consortium: outcomes of a 2-year national rare-disease gene-discovery project. Am J Hum Genet. 2014;94:809–817.
11.
Boespflug-TanguyOAubourgPDorbozI. Neurodegenerative disorder related to AIMP1/P43 mutation is not a PMLD. Am J Hum Genet. 2011;88:392–393; author reply 393-395.
12.
BiancheriRRossiAZaraFFilocamoM. AIMP1/p43 mutation and PMLD. Am J Hum Genet. 2011;88:391.
13.
ShuklaADas BhowmikAHebbarM. Homozygosity for a nonsense variant in AIMP2 is associate with a progressive neurodevelopmental disorder with microcephaly, seizure and spastic quadriparesis. J Hum Genet. 2018;63:19–25.
14.
OgnjenovićJSimonovićM. Human aminoacyl-tRNA synthetases in diseases of the nervous system. RNA Biol. 2017;23:1–12.
15.
TaftRJVanderverALeventerRJ. Mutations in DARS cause hypomyelination with brain stem and spinal cord involvement and leg spasticity. Am J Hum Genet. 2013;92:774–780.
16.
WolfNISalomonsGSRodenburgRJ. Mutations in RARS cause hypomyelination. Ann Neurol. 2014;76:134–139.
17.
MendesMIGutierrez SalazarMGuerreroK. Bi-allelic mutations in EPRS, encoding the glutamyl-prolyl-aminoacyl-tRNA synthetase, cause a hypomyelinating leukodystrophy. Am J Hum Genet. 2018;102:676–684.
18.
BreussMWSultanTJamesKN. Autosomal-recessive mutations in the tRNA splicing endonuclease subunit TSEN15 cause pontocerebellar hypoplasia and progressive microcephaly. Am J Hum Genet. 2016;99:785.
19.
MarshAPLukicVPopeK. Complete callosal agenesis, pontocerebellar hypoplasia, and axonal neuropathy due to AMPD2 loss. Neurol Genet. 2015;1:e16.
20.
Rudnik-SchönebornSBarthPGZerresK. Pontocerebellar hypoplasia. Am J Med Genet C Semin Med Genet. 2014;166C:173–183.
21.
CoughlinCRScharerGHFriederichMW. Mutations in the mitochondrial cysteinyl-tRNA synthase gene, CARS2, lead to a severe epileptic encephalopathy and complex movement disorder. J Med Genet. 2015;52:532–540.
22.
MusanteLPüttmannLKahriziK. Mutations of the aminoacyl-tRNA-synthetases SARS and WARS2 are implicated in the etiology of autosomal recessive intellectual disability. Hum Mutat. 2017;38:621–636.
23.
LatourPThauvin-RobinetCBaudelet-MéryC. A major determinant for binding and aminoacylation of tRNA(Ala) in cytoplasmic Alanyl-tRNA synthetase is mutated in dominant axonal Charcot-Marie-Tooth disease. Am J Hum Genet. 2010;86:77–82.
24.
GonzalezMMcLaughlinHHouldenH. Exome sequencing identifies a significant variant in methionyl-tRNA synthetase (MARS) in a family with late-onset CMT2. J Neurol Neurosurg Psychiatry. 2013;84:1247–1249.
NovarinoGFenstermakerAGZakiMS. Exome sequencing links corticospinal motor neuron disease to common neurodegenerative disorders. Science. 2014;343:506–511.
27.
Laser-AzoguiAKornreichMMalka-GiborEBeckR. Neurofilament assembly and function during neuronal development. Curr Opin Cell Biol. 2015;32:92–101.
28.
PerrotRBergesRBocquetAEyerJ. Review of the multiple aspects of neurofilament functions, and their possible contribution to neurodegeneration. Mol Neurobiol. 2008;38:27–65.
29.
Lépinoux-ChambaudCEyerJ. Review on intermediate filaments of the nervous system and their pathological alterations. Histochem Cell Biol. 2013;140:13–22.
